Results 201 to 210 of about 57,565 (259)

The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis. [PDF]

open access: yesVirchows Arch
Davidson B   +6 more
europepmc   +1 more source

Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype. [PDF]

open access: yesPLoS One
Ning X   +7 more
europepmc   +1 more source

Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview. [PDF]

open access: yesThorac Cancer
Pagliaro R   +10 more
europepmc   +1 more source

The pathogenesis of mesothelioma

Seminars in Oncology, 2002
About 80% of malignant mesotheliomas (MM) in the Western World develop in individuals with higher than background exposure to asbestos. Only a fraction of those exposed to asbestos develop mesothelioma, indicating that additional factors play a role. Simian virus 40 (SV40), a DNA tumor virus that preferentially causes mesothelioma in hamsters, has been
Michele, Carbone   +2 more
openaire   +2 more sources

Hyponatraemia and mesothelioma

British Journal of Diseases of the Chest, 1979
Hyponatraemia was found in 18 (62%) of 29 patients with histologically proven mesothelioma. The mechanism for the development of the hyponatraemia is discussed. It is suggested that patients with mesothelioma should be monitored for electrolyte abnormalities.
W H, Perks, R, Stanhope, M, Green
openaire   +2 more sources

Pleural mesothelioma

Medicina Clínica (English Edition), 2022
The diagnosis of diffuse pleural mesothelioma requires in most cases a pleural biopsy, performed either under imaging guidance (ultrasound or computed tomography) or thoracoscopy. Loss of BAP1 or MTAP expression (immunohistochemistry) and homozygous deletion of CDKN2A (fluorescence in situ hybridization) are the basic molecular markers for the ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy